wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37117967-2F9536C2-6529-416A-87CE-A6666CE288C1
Q37117967-2F9536C2-6529-416A-87CE-A6666CE288C1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37117967-2F9536C2-6529-416A-87CE-A6666CE288C1
Outcome after failure of second generation tyrosine kinase inhibitors treatment as first-line therapy for patients with chronic myeloid leukemia
P2860
Q37117967-2F9536C2-6529-416A-87CE-A6666CE288C1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37117967-2F9536C2-6529-416A-87CE-A6666CE288C1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
822f1e2d2a606c00524cd9f4ebd5d20a41b27aef
P2860
Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure